Literature DB >> 19542061

The descriptive epidemiology of congenital and acquired cryptorchidism in a UK infant cohort.

C L Acerini1, H L Miles, D B Dunger, K K Ong, I A Hughes.   

Abstract

INTRODUCTION: Recent studies in other European countries suggest that the prevalence of congenital cryptorchidism continues to increase. This study aimed to explore the prevalence and natural history of congenital cryptorchidism in a UK centre.
METHODS: Between October 2001 and July 2008, 784 male infants were born in the prospective Cambridge Baby Growth Study. 742 infants were examined by trained research nurses at birth; testicular position was assessed using standard techniques. Follow-up assessments were completed at ages 3, 12, 18 and 24 months in 615, 462, 393 and 326 infants, respectively.
RESULTS: The prevalence of cryptorchidism at birth was 5.9% (95% CI 4.4% to 7.9%). Congenital cryptorchidism was associated with earlier gestational age (p<0.001), lower birth weight (p<0.001), birth length (p<0.001) and shorter penile length at birth (p<0.0001) compared with other infants, but normal size after age 3 months. The prevalence of cryptorchidism declined to 2.4% at 3 months, but unexpectedly rose again to 6.7% at 12 months as a result of new cases. The cumulative incidence of "acquired cryptorchidism" by age 24 months was 7.0% and these cases had shorter penile length during infancy than other infants (p = 0.003).
CONCLUSIONS: The prevalence of congenital cryptorchidism was higher than earlier estimates in UK populations. Furthermore, this study for the first time describes acquired cryptorchidism or "ascending testis" as a common entity in male infants, which is possibly associated with reduced early postnatal androgen activity.

Entities:  

Mesh:

Year:  2009        PMID: 19542061     DOI: 10.1136/adc.2008.150219

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  33 in total

Review 1.  Physical deformities relevant to male infertility.

Authors:  Rajender Singh; Alaa J Hamada; Laura Bukavina; Ashok Agarwal
Journal:  Nat Rev Urol       Date:  2012-02-21       Impact factor: 14.432

2.  Male reproductive disorders, diseases, and costs of exposure to endocrine-disrupting chemicals in the European Union.

Authors:  Russ Hauser; Niels E Skakkebaek; Ulla Hass; Jorma Toppari; Anders Juul; Anna Maria Andersson; Andreas Kortenkamp; Jerrold J Heindel; Leonardo Trasande
Journal:  J Clin Endocrinol Metab       Date:  2015-03-05       Impact factor: 5.958

Review 3.  Surgical approach to the palpable undescended testis.

Authors:  Reju J Thomas; Andrew J A Holland
Journal:  Pediatr Surg Int       Date:  2014-05-29       Impact factor: 1.827

4.  Initial laparoscopy and optimized approach for unilateral nonpalpable testis: review of 8-year single-center experience.

Authors:  Ahmed Zaki Mohamed Anwar; Tarek Khalaf Fathelbab; Amr Mohamed Abdelhamid; Ehab Mohmed Galal; Mostafa Magdi Ali; Ehab Rifat Tawfiek
Journal:  Int Urol Nephrol       Date:  2018-10-11       Impact factor: 2.370

5.  Current referral patterns and means to improve accuracy in diagnosis of undescended testis.

Authors:  Warren Snodgrass; Nicol Bush; Michael Holzer; Song Zhang
Journal:  Pediatrics       Date:  2011-01-24       Impact factor: 7.124

6.  Diagnostic imaging in cryptorchidism: utility, indications, and effectiveness.

Authors:  Gregory E Tasian; Hillary L Copp; Laurence S Baskin
Journal:  J Pediatr Surg       Date:  2011-12       Impact factor: 2.545

Review 7.  Diagnostic performance of ultrasound in nonpalpable cryptorchidism: a systematic review and meta-analysis.

Authors:  Gregory E Tasian; Hillary L Copp
Journal:  Pediatrics       Date:  2010-12-13       Impact factor: 7.124

Review 8.  Testicular descent: INSL3, testosterone, genes and the intrauterine milieu.

Authors:  Katrine Bay; Katharina M Main; Jorma Toppari; Niels E Skakkebæk
Journal:  Nat Rev Urol       Date:  2011-03-15       Impact factor: 14.432

9.  Murine model indicates 22q11.2 signaling adaptor CRKL is a dosage-sensitive regulator of genitourinary development.

Authors:  Meade Haller; Qianxing Mo; Akira Imamoto; Dolores J Lamb
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

Review 10.  EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals.

Authors:  A C Gore; V A Chappell; S E Fenton; J A Flaws; A Nadal; G S Prins; J Toppari; R T Zoeller
Journal:  Endocr Rev       Date:  2015-11-06       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.